No black box warning on record for Defitelio

As of the latest FDA labeling reviewed, Defitelio (DEFIBROTIDE SODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Defitelio medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hemorrhage: Monitor patients for bleeding. Withhold or discontinue DEFITELIO if significant bleeding occurs. ( 2.3 , 5.1 ) • Hypersensitivity Reactions: If severe or life threatening allergic reaction occurs, discontinue DEFITELIO, treat according to standard of care, and monitor until signs and symptoms resolve. ( 2.3 , 5.2 ) 5.1 Hemorrhage DEFITELIO increased the act

No black box warning on record for Defitelio

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Hemorrhage: Monitor patients for bleeding. Withhold or discontinue DEFITELIO if significant bleeding occurs. ( 2.3 , 5.1 ) • Hypersensitivity Reactions: If severe or life threatening allergic reaction occurs, discontinue DEFITELIO, treat according to standard of care, and monitor until signs and symptoms resolve. ( 2.3 , 5.2 ) 5.1 Hemorrhage DEFITELIO increased the act

Defitelio Black Box Warning

No black box warning on record for Defitelio

Other warnings & precautions

Defitelio Black Box Warning

No black box warning on record for Defitelio

Other warnings & precautions